Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia
To assess concordance between self-reported amphetamine-type stimulant (ATS) use and toxicology results among young female sex workers (FSW) in Phnom Penh, Cambodia.
Cross-sectional data from the Young Women’s Health Study-2 (YWHS-2), a prospective study of HIV and ATS use among young (15 to 29 years) FSW in Phnom Penh, Cambodia, was analyzed. The YWHS-2 assessed sociodemographic characteristics, HIV serology, HIV risk, and ATS use by self-report and urine toxicology testing at each quarterly visit, the second of which provided data for this assessment. Outcomes include sensitivity, specificity, positive- and negative predictive values (overall and stratified by age), sex-work setting, and HIV status.
Among 200 women, prevalence of positive toxicology screening for ATS use was 14% (95% confidence interval [CI], 9.2, 18.9%) and concurrent prevalence of self-reported ATS was 15.5% (95% CI, 10.4, 20.6%). The sensitivity and specificity of self-reported ATS use compared to positive toxicology test results was 89.3% (25/28), and 96.5% (166/172), respectively. The positive predictive value of self-reported ATS use was 80.6% (25/31); the negative predictive value was 98.2% (166/169). Some differences in concordance between self-report and urine toxicology results were noted in analyses stratified by age group and sex-work setting but not by HIV status.
Results indicate a high prevalence of ATS use among FSW in Phnom Penh, Cambodia, and high concordance between self-reported and toxicology-test confirmed ATS use.
- Mills E, Singh S, Orbinski J, Burrows D: The HIV/AIDS epidemic in Cambodia. Lancet Infect Dis 2005,5(10):596–597. CrossRef
- NCHADS: Ministry of Health National Center for HIV, AIDS, Dermatology and STDs. Annual Report; 2009. [http://www.nchads.org/report.php].
- Couture MC, Sansothy N, Sapphon V, Phal S, Sichan K, Stein E, Evans J, Maher L, Kaldor J, Vun MC, et al.: Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis 2010,38(1):33–39.
- Sopheab H, Morineau G, Neal JJ, Saphonn V, Fylkesnes K: Sustained high prevalence of sexually transmitted infections among female sex workers in Cambodia: high turnover seriously challenges the 100 % Condom Use Programme. BMC Infect Dis 2008, 8:167. CrossRef
- Sopheab H, Saphonn V, Chhea C, Fylkesnes K: Distribution of HIV in Cambodia: findings from the first national population survey. AIDS 2009,23(11):1389–1395. CrossRef
- Charles M: HIV epidemic in Cambodia, one of the poorest countries in Southeast Asia: a success story. Expert Rev Anti Infect Ther 2006,4(1):1–4. CrossRef
- World Health Organization Regional Office for the Western Pacific: Controlling STI and HIV in Cambodia: The success of condom promotion. [http://wwwwhoint/hiv/topics/vct/sw_toolkit/controlling_sti_campdf].
- Sopheab H, Fylkesnes K, Vun MC, O'Farrell N: HIV-related risk behaviors in Cambodia and effects of mobility. J Acquir Immune Defic Syndr 2006,41(1):81–86. CrossRef
- Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, Page K: Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend 2012,120(1–3):119–126. CrossRef
- Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K: Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy 2011,22(3):203–209. CrossRef
- Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T: The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006,31(5):301–313.
- McKetin R, Kozel N, Douglas J, Ali R, Vicknasingam B, Lund J, Li JH: The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev 2008,27(3):220–228. CrossRef
- Boddiger D: Metamphetamine use linked to rising HIV transmission. Lancet 2005,365(9466):1217–1218. CrossRef
- Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A: Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case–control study. BMJ 2003,326(7384):308. CrossRef
- Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL: Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J Drug Alcohol Abuse 2009,35(5):295–300. CrossRef
- Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL: Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs 2010,42(1):11–18. CrossRef
- Colfax G, Shoptaw S: The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005,2(4):194–199. CrossRef
- Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R: Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999,25(3):475–493. CrossRef
- Wohl AR, Johnson DF, Lu S, Jordan W, Beall G, Currier J, Simon PA: HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr 2002,31(3):354–360. CrossRef
- United Nations Office on Drugs and Crime: Patterns and Trends of Amphetamine-Type Stimulants and Other Drugs: Asia and the Pacific. 2010. [http://www.unodc.org/documents/scientific/ATS_Report_2010_web.pdf].
- National Authority for Combating Drugs: Report on Illicit Drug Data and Routine Surveillance Systems. 2007. [http://www.unodc.org/documents/eastasiaandpacific/Publications/Projects/NACD_Annual_report2007.pdf].
- Dillon FR, Turner CW, Robbins MS, Szapocznik J: Concordance among biological, interview, and self-report measures of drug use among African American and Hispanic adolescents referred for drug abuse treatment. Psychol Addict Behav 2005,19(4):404–413. CrossRef
- De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L: Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol 1996,143(7):725–732. CrossRef
- Latkin CA, Vlahov D, Anthony JC: Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993,88(4):517–526. CrossRef
- Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, Shi Q, Hagan H, Friedman SR: Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999,353(9165):1657–1661. CrossRef
- Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, et al.: Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol 2000,152(2):99–106.
- Harrison L: The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 1997, 167:17–36.
- Fendrich M, Johnson TP: Race/ethnicity differences in the validity of self-reported drug use: results from a household survey. J Urban Health 2005,82(2 Suppl 3):iii67-iii81. CrossRef
- Fendrich M, Xu Y: The validity of drug use reports from juvenile arrestees. Int J Addict 1994,29(8):971–985.
- Rosay AB, Najaka SS, Herz D: Differences in the validity of self-reported drug use across five factors: gender, race, age, type of drug, and offense seriousness. J of Quantitative Criminology 2007,23(1):41–58. CrossRef
- Sherman MF, Bigelow GE: Validity of patients' self-reported drug use as a function of treatment status. Drug Alcohol Depend 1992,30(1):1–11. CrossRef
- Elman I, Krause S, Breiter HC, Gollub RL, Heintges J, Baumgartner WA, Rosen BR, Gastfriend DR: The validity of self-reported drug use in non-treatment seeking individuals with cocaine dependence: correlation with biochemical assays. Am J Addict 2000,9(3):216–221. CrossRef
- Weatherby NL, Needle R, Cesari H, Booth R, McCoy CB, Watters JK, Williams M, Chitwood DD: Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann 1994,17(4):347–355. CrossRef
- Hser YI, Maglione M, Boyle K: Validity of self-report of drug use among STD patients, ER patients, and arrestees. Am J Drug Alcohol Abuse 1999,25(1):81–91. CrossRef
- Magura S, Kang SY: Validity of self-reported drug use in high risk populations: a meta-analytical review. Subst Use Misuse 1996,31(9):1131–1153. CrossRef
- Hser YI: Self-reported drug use: results of selected empirical investigations of validity. NIDA Res Monogr 1997, 167:320–343.
- Cook RF, Bernstein AD, Andrews CM: Assessing drug use in the workplace: a comparison of self-report, urinalysis, and hair analysis. NIDA Res Monogr 1997, 167:247–272.
- Zanis DA, McLellan AT, Randall M: Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend 1994,35(2):127–132. CrossRef
- Harrison L: The validity of self-reported data on drug use. Journal of Drug Issues 1995,25(1):91–111.
- Williams RJ, Nowatzki N: Validity of adolescent self-report of substance use. Subst Use Misuse 2005,40(3):299–311. CrossRef
- Cook RF, Bernstein AD, Arrington TL, Andrews CM, Marshall GA: Methods for assessing drug use prevalence in the workplace: a comparison of self-report, urinalysis, and hair analysis. Int J Addict 1995,30(4):403–426.
- Prendergast M, Podus D, Finney J, Greenwell L, Roll J: Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006,101(11):1546–1560. CrossRef
- Lee NK, Rawson RA: A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008,27(3):309–317. CrossRef
- Rawson RA, Gonzales R, Brethen P: Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 2002,23(2):145–150. CrossRef
- Rawson RA, Gonzales R, Marinelli-Casey P, Ang A: Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am J Addict 2007,16(4):291–299. CrossRef
- Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, Gibson S, Siever M, King WD, Kao U, et al.: A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Publ Health 2006, 6:214. CrossRef
- Colfax GN, Santos GM, Das M, Santos DM, Matheson T, Gasper J, Shoptaw S, Vittinghoff E: Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry 2011,68(11):1168–1175. CrossRef
- Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Addiction Science & Clinical Practice
- Online Date
- June 2012
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. School of Public Health, University of California at Berkeley, Berkeley, California, USA
- 2. Department of Epidemiology and Biostatistics, University of California San Francisco, 50 Beale Street, Ste 1200, San Francisco, CA, 94105, USA
- 3. Cambodia National Center for HIV, AIDS, Dermatology and STDs, Phnom Penh, Cambodia
- 4. The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), Sydney, New South Wales, Australia